C5a Antagonist and Cataract Surgery in Mice
Author Information
Author(s): Suetsugu-Maki Rinako, Maki Nobuyasu, Fox Timothy P., Nakamura Kenta, Cowper.Solari Richard, Tomlinson Craig R., Qu Hongchang, Lambris John D., Tsonis Panagiotis A.
Primary Institution: University of Dayton
Hypothesis
The study evaluates the effects of a C5a receptor antagonist on epithelial to mesenchymal transition and crystallin expression after cataract surgery in mice.
Conclusion
The C5aR antagonist may help prevent secondary cataracts after surgery by regulating crystallin gene expression and reducing epithelial to mesenchymal transition.
Supporting Evidence
- Administration of a C5aR antagonist decreases EMT and cell proliferation in mice.
- Gene expression analysis shows down-regulation of crystallin genes after treatment with the antagonist.
- Statistical analysis confirms significant differences in EMT and proliferation between treated and control groups.
Takeaway
This study shows that a special medicine can help stop the eye from getting cloudy after surgery by keeping the cells from changing too much.
Methodology
Mice underwent cataract surgery and were treated with a C5aR antagonist; effects on EMT and gene expression were evaluated using staining and microarray analysis.
Limitations
The study is limited to a mouse model, which may not fully replicate human responses.
Participant Demographics
C57BL/6J female mice, eight weeks old.
Statistical Information
P-Value
p=0.02 for BrdU/Hoechst
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website